Cereblon Expression Correlates with Efficacy of Immunomodulatory Drugs in MM


Cereblon Expression Correlates with Efficacy of Immunomodulatory Drugs in MM
Slides from presentations at ASH 2012 and transcribed comments from a recent interview with A Keith Stewart, MBChB (1/9/13)
Klimowicz A et al. High cereblon protein expression correlates with improved response and survival in myeloma patients treated with lenalidomide. Proc ASH 2012;Abstract 931.

Schuster S et al. Cereblon expression predicts response, progression free and overall survival after pomalidomide and dexamethasone therapy in multiple myeloma. Proc ASH 2012;Abstract 194.

Dr Stewart is Dean for Research at the Mayo Clinic in Arizona, is Consultant in the Division of Hematology/Oncology and holds the Vasek and Anna Maria Polak Professorship in Cancer Research in Scottsdale, Arizona.